The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Methyl-N-(4-phenoxyphenyl)-2-chlorobenzenesulfonamide ID: ALA3980435
PubChem CID: 134157311
Max Phase: Preclinical
Molecular Formula: C19H16ClNO3S
Molecular Weight: 373.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(c1ccc(Oc2ccccc2)cc1)S(=O)(=O)c1ccccc1Cl
Standard InChI: InChI=1S/C19H16ClNO3S/c1-21(25(22,23)19-10-6-5-9-18(19)20)15-11-13-17(14-12-15)24-16-7-3-2-4-8-16/h2-14H,1H3
Standard InChI Key: VNNYUTBLBOCLFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.8825 -12.0185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0971 -11.2302 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3071 -11.4385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0940 -10.4172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3832 -10.0129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3787 -9.1977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0829 -8.7832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7936 -9.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7982 -10.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8202 -11.6269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6791 -10.4274 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5196 -11.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5007 -10.3863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2001 -9.9626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9142 -10.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9331 -11.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2337 -11.5964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6136 -9.9280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3319 -10.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0313 -9.8975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7454 -10.2908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7643 -11.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0649 -11.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3508 -11.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8390 -12.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
2 10 1 0
4 2 1 0
5 11 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
18 19 1 0
15 18 1 0
10 12 1 0
10 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.86Molecular Weight (Monoisotopic): 373.0539AlogP: 4.96#Rotatable Bonds: 5Polar Surface Area: 46.61Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.79CX LogD: 4.79Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.63Np Likeness Score: -1.49
References 1. Yamada A, Kazui Y, Yoshioka H, Tanatani A, Mori S, Kagechika H, Fujii S.. (2016) Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists., 7 (12): [PMID:27994732 ] [10.1021/acsmedchemlett.6b00184 ]